- 06 January 2021
- Journal article
Lack of evidence of ACE2 expression and replicative infection by SARS-CoV-2 in human endothelial cells
A striking feature of severe forms of coronavirus disease 2019 (COVID-19), the current pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is severe endothelial injury with micro- and macrothrombotic disease in the lung and other organs, including the heart. This has led to speculation that viral infection may damage the endothelium through 2 mechanisms: indirectly, via neighborhood effects, circulating mediators, and immune mechanisms or directly by viral infection of endothelial cells (ECs).
This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.
McCracken, I., Saginc, G., He, L., Huseynov, A., Daniels, A., Fletcher, S., Peghaire, C., Kalna, V., Andaloussi-mäe, M., Muhl, L., Craig, N., Griffiths, S., Haas, J., Tait-Burkard, C., Lendahl, U., Birdsey, G., Betsholtz, C., Noseda, M., Baker, A. & Randi, A. 2021, 'Lack of evidence of ACE2 expression and replicative infection by SARS-CoV-2 in human endothelial cells', Circulation, 143(8), pp. 865-868. https://doi.org/10.1161/CIRCULATIONAHA.120.052824